Sectors
Geographic growth and the integration of the corporate-backed healthcare venture firm's newest partner is set to precede a busy year, Rob Coppedge and Hayley Hovious told Global Venturing.
Q&A with Lukasz Garbowski, investment director, Btomorrow Ventures
Kaloyan Andonov spoke to Anil Achyuta, investment director of TDK Ventures – the venturing arm of the Japan-based materials group TDK – about the role of advanced materials in decarbonisation, electrification, 3D printing and battery recycling
Q&A with Bonnie Chau, portfolio manager, BCF Ventures
The corporate's specialty product offshoot will house investment vehicle Solvay Ventures, Matt Jones and Coppelia Marincovic told Global Corporate Venturing.
Q&A with Meryem Aydin, senior investment analyst, Amadeus Ventures
Q&A with Josh Lumer, principal, Allstate Strategic Ventures
Q&A with Gonzalo Soriano, senior investment analyst, AC Ventures
Managing director Dede Goldschmidt spelled out the unit's investment strategy along with its place in Samsung's corporate VC activities and the state of the post-pandemic market.
With a remit across healthcare, life sciences and advanced materials, Merck’s corporate venturing unit is scoping an opportunity-filled landscape.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
